The stock market continues to be a hot topic of conversation, and investors are always looking for insights from Wall Street analysts. This week, several analysts have released new ratings on various companies, offering valuable perspectives for potential investors.
Rodman & Renshaw’s Brandon Folkes
has initiated coverage on several companies, issuing Buy ratings on the following:*
Adial Pharmaceuticals, Inc. (ADIL):
Folkes has assigned a Buy rating to Adial Pharmaceuticals with a price target of $8. This represents a significant upside potential considering the stock closed at $0.9910 on Wednesday.*
Achieve Life Sciences, Inc (ACHV):
Folkes is also bullish on Achieve Life Sciences, giving it a Buy rating and a price target of $12. This compares favorably to the Wednesday closing price of $4.53.*
Rockwell Medical, Inc. (RMTI):
Folkes sees value in Rockwell Medical, issuing a Buy rating and a price target of $5. This is a notable increase from the Wednesday closing price of $2.63.Meanwhile, other analysts are also weighing in:
*
Truist Securities’ Keith Hughes
has initiated coverage onCarlisle Companies Incorporated (CSL)
with a Hold rating and a price target of $460. The stock closed at $454.83 on Wednesday.*
Oppenheimer’s Ian Zaffino
has initiated coverage onTurning Point Brands, Inc. (TPB)
with an Outperform rating and a price target of $65. This optimistic outlook follows the stock’s Wednesday closing price of $55.00.These ratings are valuable tools for investors to consider as they navigate the market. While analysts’ opinions can provide insights, it’s crucial to conduct your own due diligence and make informed decisions based on your individual investment strategy.
